BRESOTEC
DEAD

Serial Number

90513380

Owner

BresoTec Inc.

Attorney

Allison Z. Gifford

Filing Date

Feb 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BRESOTEC Trademark

Serial Number: 90513380

BRESOTEC is a trademark filed by BresoTec Inc. on February 5, 2021. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

BresoTec Inc. (3 trademarks)

550 University Avenue, Room 12-159
Toronto, Ontario M5G2A2 , CA

Entity Type: 03

Trademark Details

Filing Date

February 5, 2021

Registration Date

Not Registered

Goods & Services

Downloadable computer software for use in sleep apnea diagnosis and in calculating, analyzing and evaluating apnea hypopnea index (AHI)

Data management services, namely, compilation of information related to data in the field of sleep patterns and sleep apnea into computer databases; commercialization of new technologies and software solutions in the field of sleep studies and sleep apnea, namely, new product commercialization services

Medical analysis of sleep data in the nature of medical analysis services relating to the treatment of persons; clinical medical consultation services in the field of sleep and sleep apnea; medical analysis services, namely, analysis of sleep data for the purpose of assisting in the diagnosis of sleep apnea and sleep disorders; medical analysis services, namely, providing automated analysis relating to data in the field of sleep patterns and sleep apnea for the purpose of assisting in the diagnosis of sleep apnea and sleep disorders

Electronic personal health monitoring device consisting of a wireless portable and wearable fitted device for the head with microphone for capturing and recording breathing sounds and patterns for the purpose of sleep apnea diagnosis; electronic personal health monitoring device consisting of a patch sensor for recording breathing and body movements and a pulse oximeter for recording blood oxygen, oxygen saturation and heart rate of the wearer, for the purpose of sleep apnea diagnosis and gathering of sleep data; electronic personal health device consisting of wearable sensors and monitors used to measure biometric data for medical use for the purpose of sleep apnea diagnosis and gathering of sleep data

Software as a service (SaaS) featuring software for analyzing and recording biometric measurements and patterns related to sleep in the field of sleep studies and sleep apnea; software as a service (SaaS) featuring software for monitoring blood oxygen saturation, heart rate, breath sounds, physical movements and other inputs used to assist in assessing sleep parameters of a patient; software as a service (SaaS) featuring artificial intelligence software for analyzing data relating to sleep patterns and sleep apnea and viewing of test results; software as a service (SaaS) featuring software for storing, viewing and manipulating patient data relating to sleep patterns and sleep apnea; medical research services, namely, providing automated analysis and data management relating to data in the field of sleep patterns and sleep apnea data; data analysis in the nature of medical research; medical analysis of sleep data in the nature of medical research in the field of sleep apnea; consulting services in the field of product development and engineering in the field of sleep studies and sleep apnea; product development of new technologies and software solutions in the field of sleep studies and sleep apnea; product innovation in the field of sleep studies and sleep apnea, namely, product research and development; medical research in the field of sleep studies and sleep apnea

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 26, 2024 MAB2
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jan 26, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jan 26, 2024 ABN2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 12, 2023 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 12, 2023 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 12, 2023 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 14, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 14, 2023 GNSL
SUSPENSION LETTER WRITTEN
Apr 14, 2023 CNSL
EXAMINER'S AMENDMENT ENTERED
Apr 14, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 14, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 14, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 14, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 21, 2023 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sep 23, 2022 GNS2
INQUIRY TO SUSPENSION E-MAILED
Sep 23, 2022 GNSI
SUSPENSION INQUIRY WRITTEN
Sep 23, 2022 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 22, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 22, 2022 GNSL
SUSPENSION LETTER WRITTEN
Mar 22, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 3, 2022 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Sep 3, 2021 GPRN
PRIORITY ACTION E-MAILED
Sep 3, 2021 GPRA
PRIORITY ACTION WRITTEN
Sep 3, 2021 CPRA
ASSIGNED TO EXAMINER
Aug 28, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2021 NWOS
NEW APPLICATION ENTERED
Feb 9, 2021 NWAP